news
Induced pluripotent stem cells (iPSC) intestinal organoids have been created…
14 April 2021 | By Victoria Rees (Drug Target Review)
Induced pluripotent stem cells (iPSC) intestinal organoids have been created to duplicate SARS-CoV-2, enabling drug testing.